1. Home
  2. CDT vs BAOS Comparison

CDT vs BAOS Comparison

Compare CDT & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDT
  • BAOS
  • Stock Information
  • Founded
  • CDT 2019
  • BAOS 2018
  • Country
  • CDT United States
  • BAOS China
  • Employees
  • CDT N/A
  • BAOS N/A
  • Industry
  • CDT Biotechnology: Pharmaceutical Preparations
  • BAOS Business Services
  • Sector
  • CDT Health Care
  • BAOS Consumer Discretionary
  • Exchange
  • CDT Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • CDT 3.1M
  • BAOS 3.6M
  • IPO Year
  • CDT N/A
  • BAOS 2021
  • Fundamental
  • Price
  • CDT $2.15
  • BAOS $3.28
  • Analyst Decision
  • CDT
  • BAOS
  • Analyst Count
  • CDT 0
  • BAOS 0
  • Target Price
  • CDT N/A
  • BAOS N/A
  • AVG Volume (30 Days)
  • CDT 57.3K
  • BAOS 65.0K
  • Earning Date
  • CDT 11-14-2025
  • BAOS 12-26-2025
  • Dividend Yield
  • CDT N/A
  • BAOS N/A
  • EPS Growth
  • CDT N/A
  • BAOS N/A
  • EPS
  • CDT N/A
  • BAOS N/A
  • Revenue
  • CDT N/A
  • BAOS $624,087.00
  • Revenue This Year
  • CDT N/A
  • BAOS N/A
  • Revenue Next Year
  • CDT N/A
  • BAOS N/A
  • P/E Ratio
  • CDT N/A
  • BAOS N/A
  • Revenue Growth
  • CDT N/A
  • BAOS N/A
  • 52 Week Low
  • CDT $1.61
  • BAOS $1.44
  • 52 Week High
  • CDT $2,198.40
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • CDT 47.44
  • BAOS 63.27
  • Support Level
  • CDT $1.61
  • BAOS $2.22
  • Resistance Level
  • CDT $2.84
  • BAOS $2.54
  • Average True Range (ATR)
  • CDT 0.21
  • BAOS 0.22
  • MACD
  • CDT -0.08
  • BAOS 0.09
  • Stochastic Oscillator
  • CDT 39.19
  • BAOS 91.52

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: